CWM
KYMR icon

CIBC World Markets’s Kymera Therapeutics KYMR Stock Holding History

CIBC World Markets’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$290K Buy
+3,732
New +$252K ﹤0.01% 968
2025
Q2 		$252K Sell
5,767
-4,651
-45% -$160K ﹤0.01% 1180
2025
Q1 		$285K Buy
+10,418
New +$380K ﹤0.01% 1277

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

CIBC World Markets's KYMR Position: Q4 2025 in Review

CIBC World Markets opened a new position in Kymera Therapeutics (KYMR) in Q4 2025: 3,732 shares worth $290K. The stake represents ﹤0.01% of the portfolio and ranks #968 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in KYMR as recently as Q2 2025.

CIBC World Markets first reported a position in KYMR in Q1 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold KYMR as of Q4 2025.

  • CIBC World Markets held 3,732 shares of Kymera Therapeutics worth $290K as of Q4 2025.
  • Kymera Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Kymera Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #968 holding.
  • CIBC World Markets first reported a position in Kymera Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.